RVTY vs SNGX · P/E 42, rev $1.44B vs $6.0M cap
Revvity Inc. (RVTY) versus Soligenix Inc. (SNGX) — a side-by-side from cached financials, not a winner call.
Revvity Inc. (RVTY) is a diagnostics & research company listed on US.
Soligenix Inc. (SNGX) is a biotechnology company listed on NASDAQ.
Latest reported RVTY revenue for 2026-07-05 was $1.44B. Net income was $92.5M. RVTY currently screens at market cap $11.94B and trailing P/E 41.9.
SNGX does not have a complete income-statement cache yet.
RVTY currently screens at market cap $11.94B and trailing P/E 41.9. SNGX currently screens at market cap $6.0M.
Not investment advice. Open the RVTY and SNGX stock pages for the full models.
Not investment advice.